Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)

קרןNational Cancer Institute/NIH
סוגResearch Grants
תאריך אחרון29/09/2020
פקולטהEngineering, Exact Sciences, Life Sciences, Medicine

applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. R33 supports Phase II of an exploratory/developmental Grant. 


Funding: $300,000 per year

Duration: 3 years


Research Authority due date: 10 days prior to submission

LOI (encouraged) due date: 21.1.20, 28.4.20, 29.8.20

Full proposal due date: 21.2.20, 28.5.20, 29.9.20

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 05/12/2019
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive